G2GBIO: 투자판단관련주요경영사항(임상시험결과)

August 27, 2026 · KOSDAQ · Market cap ₩533.0bn · G2GBIO chart & price →
AI reading
★★★ Neutral · Material event

알츠하이머성 치매 치료제(GB-5001) 임상 1상 결과 공시

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

Other filings by G2GBIO
All of today's important filings (Filings Radar) →

For information only. Not investment advice.